A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Stimulants
This training will review the available evidence for the use of medications to treat stimulant use disorders in patients who can become pregnant. The session will emphasize the importance of shared-decision making with pregnant patients to optimize outcomes related to stimulant use disorders and medication interventions.
![]() |
Thursday, 6/5/2025 12:30 pm – 1:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, peer supports, other clinical staff, and non-clinicians. |
Topic: CARN and CARN-AP
This training is meant for Registered Nurses (RNs) and Advanced Practice Registered Nurses (APRNs) working in the addiction field who are interested in becoming Certified Addictions Registered Nurse (CARN) or a Certified Addictions Registered Nurse - Advanced Practice (CARN-AP). The course is intended to support nurses studying for the certification exam by reviewing content covered in the exam and providing additional educational resources relevant to the exam.
![]() |
Monday, 6/9/2025 9:00 am – 12:00 pm ET |
![]() |
Virtual event |
![]() |
Intended AudienceRegistered Nurses (RNs) and Advanced Practice Registered Nurses (APRNs) with experience treating patients with addiction who intend to sit for the CARN or CARN-AP exam. |
Topic: ECHO
As part of the twice-monthly MA OBAT ECHO® series, Holly Echo-Hawk, MSc, will discuss the prevalence of substance use disorders (SUD) among Indigenous populations and review culturally specific SUD treatment considerations for Indigenous people. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
![]() |
Tuesday, 6/10/2025 7:30 am – 9:00 am ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Infectious Disease and Overdose Prevention
This training covers sexually transmitted infections, skin and soft tissue infections, and respiratory infections.
![]() |
Tuesday, 6/10/2025 10:00 am – 11:00 am ET |
![]() |
Virtual event |
![]() |
Intended AudienceNurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Xylazine
This training provides knowledge on xylazine, a CNS depressant, linked to an increasing number of overdose deaths in the US. This describes the physiologic effects of xylazine, manifestations of xylazine intoxication, overdose, communicable infections associated with xylazine use, and wound care for persons injecting xylazine.
![]() |
Wednesday, 6/11/2025 2:00 pm – 3:00 pm ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Office Hours
A virtual open forum session where clinical providers and staff supporting those with substance use can drop in with addiction-related questions or brief de-identified challenging cases for discussion.
![]() |
Thursday, 6/12/2025 5:00 pm – 6:00 pm ET |
![]() |
Virtual event |
![]() |
Intended AudienceClinical providers and staff supporting those with substance use. |
Topic: Alcohol
This training is designed to provide an introductory overview of alcohol use disorders. We will explore the latest epidemiological data, with a focus on the prevalence and trends of alcohol use and alcohol use disorders in the United States. Diagnostic criteria and screening tools to assess for alcohol use disorders will be discussed. Additionally, we will examine evidence-based interventions to treat alcohol use disorders and support individuals in their recovery.
![]() |
Friday, 6/13/2025 1:00 pm – 2:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Stimulants
This training provides an introduction to stimulant use disorder, including evidence-informed treatments and interventions.
![]() |
Thursday, 6/19/2025 1:00 pm – 2:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Buprenorphine
This training provides healthcare teams with information on the available extended-release injectable buprenorphine formulations for the treatment of opioid use disorder and how to implement them into clinical practice.
![]() |
Friday, 6/20/2025 10:00 am – 11:00 am ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudiencePhysicians, advanced practice providers, nurses, social workers, recovery coaches, and all other healthcare professionals treating addiction. |
Topic: ECHO
As part of the twice-monthly MA OBAT ECHO® series, Ruth Potee, MD, will review the basics of methadone treatment for opioid use disorder and discuss changes in rules and regulations following the Modernizing Opioid Treatment Access Act. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
![]() |
Tuesday, 6/24/2025 7:30 am – 9:00 am ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |